Economic malpractice in the treatment of Gaucher's disease
- 31 July 1994
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (1) , 1-2
- https://doi.org/10.1016/0002-9343(94)90041-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatmentThe American Journal of Medicine, 1994
- Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patientsBlood, 1993
- Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsBlood, 1993
- Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.Journal of Clinical Investigation, 1993
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Gaucher DiseaseMedicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991